Status:
UNKNOWN
Immune Function in Elderly Patients With Mild to Moderate COVID-19 on Hemodialysis
Lead Sponsor:
Ruijin Hospital
Conditions:
COVID-19
Hemodiafiltration
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This randomized controlled trial will focus on the effects of early oral nutritional supplementation on immune function in elderly patients with mild to moderate COVID-19 on maintenance hemodialysis. ...
Detailed Description
COVID-19 is in the midst of a global pandemic. Elderly patients are often susceptible and at high risk. Elderly patients on maintenance hemodialysis are often accompanied by a variety of complications...
Eligibility Criteria
Inclusion
- Aged 60 and above;
- Patients receiving hemodialysis with clinically confirmed end-stage renal disease
- Positive diagnosis of COVID-19 by RT-PCR nasopharyngeal swab was classified as mild or moderate type
- Patients who can eat on their own;
- Patients had good compliance, fully understood the study content and signed informed consent.
Exclusion
- Contraindications of oral nutritional supplementation, such as intestinal obstruction and intestinal ischemia.
- In an unstable state of vital signs such as shock.
- In acute pancreatitis, cholecystitis acute attack period and 3 months after the last attack
- Patients with moderate to severe cognitive impairment or mental diseases;
- People who are allergic to intestinal nutrients
- Refuse oral nutritional supplements
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT05366205
Start Date
May 1 2022
End Date
August 31 2022
Last Update
May 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.